{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:51:41Z","timestamp":1781700701944,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01906-4","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:21:27Z","timestamp":1758882087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic impact of non-clear cell histology on recurrence and cancer-free survival in renal cell carcinoma: a time-to-event analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Waseem","family":"Tayeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohnna","family":"Subahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hattan","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turky","family":"Almohaisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elkoushy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1906_CR1","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.","journal-title":"Nat Rev Dis Primers"},{"key":"1906_CR2","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1906_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036]","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74\u201384. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.036].","journal-title":"Eur Urol"},{"issue":"36","key":"1906_CR4","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1200\/JCO.2014.56.5416","volume":"32","author":"SB Stewart","year":"2014","unstructured":"Stewart SB, Thompson RH, Psutka SP, et al. Evaluation of the National comprehensive cancer network and American urological association renal cell carcinoma surveillance guidelines. J Clin Oncol. 2014;32(36):4059\u201365.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1906_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/01.ju.0000165572.38887.da","volume":"174","author":"JS Lam","year":"2005","unstructured":"Lam JS, Shvarts O, Leppert JT. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol. 2005;174(2):466\u201372.","journal-title":"J Urol"},{"key":"1906_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","volume":"75","author":"B Ljungberg","year":"2019","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75:799\u2013810. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.011.","journal-title":"Eur Urol"},{"key":"1906_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0094-0143(03)00056-9","volume":"30","author":"NK Janzen","year":"2003","unstructured":"Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30:843\u201352.","journal-title":"Urol Clin North Am"},{"key":"1906_CR8","first-page":"22","volume":"39","author":"T Almdalal","year":"2022","unstructured":"Almdalal T, Sundqvist P, Harmenberg U, et al. Clinical T1a renal cell carcinoma, not always a harmless Disease- A National register study. Eur Urol. 2022;39:22\u20138.","journal-title":"Eur Urol"},{"key":"1906_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","volume":"198","author":"S Campbell","year":"2017","unstructured":"Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520\u20139.","journal-title":"J Urol"},{"key":"1906_CR10","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.juro.2007.01.029","volume":"177","author":"DA Kunkle","year":"2007","unstructured":"Kunkle DA, Crispen PL, Li T, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol. 2007;177:1692\u20136.","journal-title":"J Urol"},{"issue":"10","key":"1906_CR11","first-page":"1149","volume":"28","author":"M Sundaram","year":"2022","unstructured":"Sundaram M, Song Y, Rogerio JW, et al. Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of surveillance, epidemiology, and end Results\u2013Medicare data. J Manag Care Spec Pharm. 2022;28(10):1149\u201360.","journal-title":"J Manag Care Spec Pharm"},{"key":"1906_CR12","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.3390\/cancers13153807","volume":"13","author":"P Sepe","year":"2021","unstructured":"Sepe P, Ottini A, Pircher CC, et al. Characteristics and treatment challenges of Non-Clear cell renal cell carcinoma. Cancers. 2021;13:3807\u201322.","journal-title":"Cancers"},{"issue":"4","key":"1906_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri TK, Motzer RJ. Systemic therapy for metastatic Renal-Cell carcinoma. N Engl J Med. 2017;376(4):354\u201366.","journal-title":"N Engl J Med"},{"key":"1906_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000319368","volume":"86","author":"F Rodriguez-Covarrubias","year":"2011","unstructured":"Rodriguez-Covarrubias F, Gomez-Alvarado MO, Sotomayor M, et al. Time to recurrence after nephrectomy as a predictor of cancer-specific survival in localized clear-cell renal cell carcinoma. Urol Int. 2011;86:47\u201352.","journal-title":"Urol Int"},{"key":"1906_CR15","doi-asserted-by":"publisher","first-page":"8650","DOI":"10.1038\/s41598-021-88177-9","volume":"11","author":"KE Mattila","year":"2021","unstructured":"Mattila KE, Laajala TD, Tornberg SV, et al. A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma. Sci Rep. 2021;11:8650.","journal-title":"Sci Rep"},{"key":"1906_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4111\/kju.2013.54.11.744","volume":"54","author":"H-S Son","year":"2013","unstructured":"Son H-S, Jeon SH, Chang S-G. Factors affecting the time to recurrence after radical nephrectomy for localized renal cell carcinoma. Korean J Urol. 2013;54:744\u20139.","journal-title":"Korean J Urol"},{"issue":"2","key":"1906_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00345-021-03640-6","volume":"41","author":"M Baboudjian","year":"2023","unstructured":"Baboudjian M, Gondran-Tellier B, Khene Z, et al. Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study). World J Urol. 2023;41(2):295\u2013302.","journal-title":"World J Urol"},{"issue":"12","key":"1906_CR18","doi-asserted-by":"publisher","first-page":"e0226285","DOI":"10.1371\/journal.pone.0226285","volume":"14","author":"JC van der Mijn","year":"2019","unstructured":"van der Mijn JC, Al Awamlh BA, Khan AI, et al. Validation of risk factors for recurrence of renal cell carcinoma: results from a large single-institution series. PLoS ONE. 2019;14(12):e0226285.","journal-title":"PLoS ONE"},{"key":"1906_CR19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/S0022-5347(01)63542-0","volume":"159","author":"DA Levy","year":"1998","unstructured":"Levy DA, Swanson DA, Slaton JW, et al. Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma. J Urol. 1998;159:1168\u201373.","journal-title":"J Urol"},{"key":"1906_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/01.ju.0000132126.85812.7d","volume":"172","author":"AJ Stephenson","year":"2004","unstructured":"Stephenson AJ, Chetner MP, Rourke K, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol. 2004;172:58\u201362.","journal-title":"J Urol"},{"key":"1906_CR21","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.eururo.2007.03.035","volume":"51","author":"B Ljungberg","year":"2007","unstructured":"Ljungberg B, Hanbury DC, Kuczyk MA, et al. Renal cell carcinoma guideline. Eur Urol. 2007;51:1502\u201310.","journal-title":"Eur Urol"},{"key":"1906_CR22","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S0022-5347(05)00334-4","volume":"175","author":"SE Canfield","year":"2006","unstructured":"Canfield SE, Kamat AM, S\u00e1nchez-Oritz RF, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol. 2006;175:864\u20139.","journal-title":"J Urol"},{"key":"1906_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0090-4295(02)02163-5","volume":"61","author":"KR Han","year":"2003","unstructured":"Han KR, Pantuck AJ, Bui MH, et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology. 2003;61:314\u20139.","journal-title":"Urology"},{"issue":"2","key":"1906_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3349\/ymj.2022.63.2.173","volume":"63","author":"J Lee","year":"2022","unstructured":"Lee J, Kim J, Kim JC, et al. Evaluation of the surgical margin threshold for avoiding recurrence after partial nephrectomy in patients with renal cell carcinoma. Yonsei Med J. 2022;63(2):173\u20138.","journal-title":"Yonsei Med J"},{"issue":"5","key":"1906_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","volume":"27","author":"JC Cheville","year":"2003","unstructured":"Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27(5):612\u201324.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1906_CR26","first-page":"1","volume":"8","author":"AI Chin","year":"2006","unstructured":"Chin AI, Lam JS, Figlin RA, Belldegrun AS. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006;8(1):1\u20137.","journal-title":"Rev Urol"},{"issue":"5","key":"1906_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/MOU.0000000000000308","volume":"26","author":"KA Richards","year":"2016","unstructured":"Richards KA, Abel EJ. Surveillance following surgery for non-metastatic renal cell carcinoma. Curr Opin Urol. 2016;26(5):432\u20138.","journal-title":"Curr Opin Urol"},{"key":"1906_CR28","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.5114\/pjr.2022.117593","volume":"87","author":"Y Mytsyk","year":"2022","unstructured":"Mytsyk Y, Borzhiyevskyy A, Dutka I, et al. Local recurrence of renal cell carcinoma after partial nephrectomy: applicability of the apparent diffusion coefficient of MRI as an imaging marker \u2013 a multicenter study. Pol J Radiol. 2022;87:e325\u201332.","journal-title":"Pol J Radiol"},{"issue":"3","key":"1906_CR29","doi-asserted-by":"publisher","first-page":"e25635","DOI":"10.2196\/25635","volume":"9","author":"HM Kim","year":"2021","unstructured":"Kim HM, Lee SJ, Park SJ, et al. Machine learning approach to predict the probability of recurrence of renal cell carcinoma after surgery: prediction model development study. JMIR Med Inf. 2021;9(3):e25635.","journal-title":"JMIR Med Inf"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01906-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:21:28Z","timestamp":1758882088000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01906-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01906-4","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"20 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures performed in the studies involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments. Data were collected retrospectively from medical and electronic records; therefore, ethics approval from the local institutional review board was not required. All patients included in the study provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and agree with its submission and publication in BMC Urology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}